Marty Chaplin
Overview
Explore the profile of Marty Chaplin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
405
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dey T, Cole M, Brown D, Hill R, Chaplin M, Huffstetler H, et al.
Cochrane Database Syst Rev
. 2025 Jan;
1:CD016119.
PMID: 39868519
Rationale: Postpartum haemorrhage, defined as a blood loss of 500 mL or more within 24 hours of birth, is the leading global cause of maternal morbidity and mortality. Uterine fibroids...
2.
Dey T, Brown D, Cole M, Hill R, Chaplin M, Huffstetler H, et al.
Cochrane Database Syst Rev
. 2024 Dec;
12:CD016120.
PMID: 39704317
Rationale: Postpartum haemorrhage (PPH), defined as a blood loss of 500 mL or more within 24 hours of birth, is the leading global cause of maternal morbidity and mortality. Allogenic...
3.
Kuehn R, Ryan H, Okwaraeke K, Gould S, Chaplin M, Riley M, et al.
Cochrane Database Syst Rev
. 2024 Nov;
11():CD015828.
PMID: 39560047
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects of vaccines to prevent Ebola virus disease in people who have been,...
4.
Fleeman N, Houten R, Nevitt S, Mahon J, Beale S, Boland A, et al.
Health Technol Assess
. 2024 Sep;
28(49):1-190.
PMID: 39252678
Background: Renal cell carcinoma is the most common type of kidney cancer, comprising approximately 85% of all renal malignancies. Patients with advanced renal cell carcinoma are the focus of this...
5.
Fox T, Sguassero Y, Chaplin M, Rose W, Doum D, Arevalo-Rodriguez I, et al.
Cochrane Database Syst Rev
. 2024 Apr;
4:CD015636.
PMID: 38597256
Background: Dengue is a global health problem of high significance, with 3.9 billion people at risk of infection. The geographic expansion of dengue virus (DENV) infection has resulted in increased...
6.
Chaplin M, Bresnahan R, Fleeman N, Mahon J, Houten R, Beale S, et al.
Pharmacoecon Open
. 2023 Dec;
7(6):1015.
PMID: 38051493
No abstract available.
7.
Bresnahan R, Duarte R, Mahon J, Beale S, Chaplin M, Bhattacharyya D, et al.
Health Technol Assess
. 2023 Oct;
27(10):1-115.
PMID: 37839810
Background: Magnetic resonance imaging-based technologies are non-invasive diagnostic tests that can be used to assess non-alcoholic fatty liver disease. Objectives: The study objectives were to assess the diagnostic test accuracy,...
8.
Chaplin M, Bresnahan R, Fleeman N, Mahon J, Houten R, Beale S, et al.
Pharmacoecon Open
. 2023 Sep;
7(6):863-875.
PMID: 37731145
As part of the National Institute for Health and Care Excellence (NICE) highly specialised technology (HST) evaluation programme, Novartis submitted evidence to support the use of onasemnogene abeparvovec as a...
9.
Bresnahan R, Houten R, Greenhalgh J, Nevitt S, Mahon J, Beale S, et al.
Pharmacoecon Open
. 2023 May;
7(4):525-536.
PMID: 37195551
As part of the Single Technology Appraisal (STA) process, the UK National Institute for Health and Care Excellence (NICE) invited Apellis Pharmaceuticals/Sobi to submit evidence for the clinical and cost...
10.
Houten R, Fleeman N, Mahon J, Chaplin M, Edwards K, Beale S, et al.
Pharmacoecon Open
. 2023 Apr;
7(3):345-358.
PMID: 37084172
The National Institute for Health and Care Excellence (NICE) provides guidance to improve health and social care in England and Wales. NICE invited Daiichi Sankyo to submit evidence for the...